BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Amneal Pharmaceuticals, Inc. (AMRX) (“Amneal” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has approved memantine/donepezil ...
Memantine, a drug approved for Alzheimer’s disease, was associated with significant improvement in social functioning in some children and adolescents with autism spectrum disorder (ASD) without ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results